Diagnosis & Disease Information

ESMO GI 2021

BRAF Mutant Allele Fraction May Predict Survival in Metastatic Colorectal Cancer

July 19, 2021

When researchers combined clinical features with BRAF mutant allele fraction, patients could be divided into 3 risk groups that were significantly associated with survival.

ESMO GI 2021

Dose Capping May Explain Reduced Survival in Patients With Colorectal Cancer and High BMI

Jonathan Goodman, MPhil

July 16, 2021

The results suggest a link, but more research is needed.

New advances regarding treatment options for metastatic pancreatic cancer.

Gastrointestinal Cancers

Adding Nab-Paclitaxel to Gemcitabine May Improve Overall Survival in Resected Pancreatic Cancer

Jonathan Goodman, MPhil

July 15, 2021

Nab-paclitaxel was associated with an improvement in long-term overall survival.

doctor reviewing patient chart at hospital bedside

Gastrointestinal Cancers

Pembrolizumab Improves Upon Standard Care in Gastric, Gastroesophageal Junction Cancers

Jonathan Goodman, MPhil

July 14, 2021

The results led to another approved indication for pembrolizumab.

Gastrointestinal Cancers

Antibiotic Use May Increase the Risk of Early-Onset Colon Cancer

Jonathan Goodman, MPhil

July 13, 2021

The association was observed with colon cancer but not rectal cancer.

Next post in Gastrointestinal Cancers

Diagnosis & Disease Information

BRAF Mutant Allele Fraction May Predict Survival in Metastatic Colorectal Cancer

Dose Capping May Explain Reduced Survival in Patients With Colorectal Cancer and High BMI

Adding Nab-Paclitaxel to Gemcitabine May Improve Overall Survival in Resected Pancreatic Cancer

Pembrolizumab Improves Upon Standard Care in Gastric, Gastroesophageal Junction Cancers

Antibiotic Use May Increase the Risk of Early-Onset Colon Cancer

Universal Health Care Associated With a Lower Risk of Death in Colon Cancer